• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与囊性纤维化相关的糖尿病

Diabetes mellitus associated with cystic fibrosis.

作者信息

Finkelstein S M, Wielinski C L, Elliott G R, Warwick W J, Barbosa J, Wu S C, Klein D J

机构信息

Department of Laboratory Medicine, University of Minnesota, Minneapolis 55455.

出版信息

J Pediatr. 1988 Mar;112(3):373-7. doi: 10.1016/s0022-3476(88)80315-9.

DOI:10.1016/s0022-3476(88)80315-9
PMID:3346774
Abstract

The prevalence of overt diabetes mellitus and carbohydrate intolerance was studied in 448 patients with cystic fibrosis (CF). Insulin-dependent diabetes (IDDM) developed in 7.6% of patients (13 male and 21 female). Survival was significantly lower (P less than 0.01) in the IDDM-CF group, with fewer than 25% surviving to age 30 years, whereas nearly 60% of the nondiabetic CF population reached this age. A significant deterioration in CF clinical status, based on NIH score, became apparent 2 years before onset of overt IDDM (P less than 0.05 at 2 years prior, P less than 0.01 at IDDM diagnosis). Total glycosylated hemoglobin (HbA1) was significantly (P less than 0.001) higher for the total CF population (7.3% +/- 1.2%) than for the general non-CF population (6.5% +/- 0.7%), and in the IDDM-CF group (P less than 0.05) compared with normoglycemic CF control patients. Female patients had a higher mean HbA1 after 12 years of age than their male counterparts did (P less than 0.02). HBA1 did not predict the development of IDDM, but there was a weak inverse relationship between HbA1 and both NIH clinical score (r = -0.41, P less than 0.02) and standard pulmonary function tests (forced vital capacity, r = -0.25, P less than 0.01) in the general CF population. Therefore, impaired carbohydrate tolerance in CF is associated with progressive clinical deterioration.

摘要

对448例囊性纤维化(CF)患者的显性糖尿病和碳水化合物不耐受患病率进行了研究。7.6%的患者(13名男性和21名女性)发生了胰岛素依赖型糖尿病(IDDM)。IDDM-CF组的生存率显著降低(P<0.01),30岁前存活者不到25%,而近60%的非糖尿病CF人群达到了这个年龄。基于美国国立卫生研究院(NIH)评分,CF临床状态在显性IDDM发病前2年出现显著恶化(发病前2年P<0.05,IDDM诊断时P<0.01)。CF总体人群的总糖化血红蛋白(HbA1)显著高于一般非CF人群(7.3%±1.2%对6.5%±0.7%,P<0.001),且IDDM-CF组与血糖正常的CF对照患者相比也显著升高(P<0.05)。12岁后女性患者的平均HbA1高于男性患者(P<0.02)。HbA1不能预测IDDM的发生,但在总体CF人群中,HbA1与NIH临床评分(r=-0.41,P<0.02)和标准肺功能测试(用力肺活量,r=-0.25,P<0.01)之间存在弱的负相关。因此,CF患者的碳水化合物耐受性受损与临床进行性恶化有关。

相似文献

1
Diabetes mellitus associated with cystic fibrosis.与囊性纤维化相关的糖尿病
J Pediatr. 1988 Mar;112(3):373-7. doi: 10.1016/s0022-3476(88)80315-9.
2
Glycosylated haemoglobin and glucose intolerance in cystic fibrosis.囊性纤维化中的糖化血红蛋白与葡萄糖不耐受
Arch Dis Child. 1987 Aug;62(8):805-10. doi: 10.1136/adc.62.8.805.
3
Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors.
J Pediatr Endocrinol Metab. 2001 Jan;14(1):53-60. doi: 10.1515/jpem.2001.14.1.53.
4
Hemoglobin A1 and pancreatic beta cell function in cystic fibrosis.
Isr J Med Sci. 1983 Jul;19(7):600-3.
5
Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM.
Diabetes Care. 1989 Nov-Dec;12(10):694-70. doi: 10.2337/diacare.12.10.694.
6
Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis.
J Pediatr Endocrinol Metab. 2000 Mar;13(3):319-24. doi: 10.1515/jpem.2000.13.3.319.
7
Diabetes mellitus and cystic fibrosis in 2 Saudi siblings.两名沙特兄弟姐妹患有糖尿病和囊性纤维化。
Saudi Med J. 2002 Dec;23(12):1541-5.
8
[Glucose intolerance and diabetes during cystic fibrosis].[囊性纤维化期间的葡萄糖不耐受和糖尿病]
Ann Pediatr (Paris). 1991 Apr;38(4):244-8.
9
The size of the spleen by magnetic resonance imaging in patients with cystic fibrosis; with and without diabetes--a novel observational study.磁共振成像在囊性纤维化伴或不伴糖尿病患者脾大小评估中的应用:一项新的观察性研究。
QJM. 2010 Apr;103(4):237-42. doi: 10.1093/qjmed/hcp193. Epub 2010 Feb 4.
10
Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections.囊性纤维化中的糖尿病:胰岛素治疗对肺功能和感染的影响。
Acta Paediatr. 1994 Aug;83(8):849-53. doi: 10.1111/j.1651-2227.1994.tb13156.x.

引用本文的文献

1
20 years of the Montreal Cystic Fibrosis Related Diabetes Screening Cohort: key insights.蒙特利尔囊性纤维化相关糖尿病筛查队列20年:关键见解
Eur Respir Rev. 2025 May 14;34(176). doi: 10.1183/16000617.0220-2024. Print 2025 Apr.
2
Vitamin D for glycemic control following an acute pulmonary exacerbation: A secondary analysis of a multicenter, double-blind, randomized, placebo-controlled trial in adults with cystic fibrosis.急性肺部加重期后维生素D对血糖控制的影响:一项针对成年囊性纤维化患者的多中心、双盲、随机、安慰剂对照试验的二次分析
medRxiv. 2024 Mar 10:2024.01.04.24300862. doi: 10.1101/2024.01.04.24300862.
3
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis-related diabetes in children and adolescents.
《国际儿童青少年糖尿病协会2022年临床实践共识指南:儿童和青少年囊性纤维化相关糖尿病的管理》
Pediatr Diabetes. 2022 Dec;23(8):1212-1228. doi: 10.1111/pedi.13453.
4
Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review.连续血糖监测与参考标准口服葡萄糖耐量试验在检测囊性纤维化患者血糖异常中的比较:一项系统评价。
J Clin Transl Endocrinol. 2022 Sep 27;30:100305. doi: 10.1016/j.jcte.2022.100305. eCollection 2022 Dec.
5
Increased sputum lactate during oral glucose tolerance test in cystic fibrosis.口服葡萄糖耐量试验中肺囊性纤维化患者痰液乳酸水平升高。
APMIS. 2022 Aug;130(8):535-539. doi: 10.1111/apm.13233. Epub 2022 May 30.
6
Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis.囊性纤维化相关糖尿病:患病率、筛查与诊断
J Clin Transl Endocrinol. 2021 Dec 7;27:100290. doi: 10.1016/j.jcte.2021.100290. eCollection 2022 Mar.
7
Impaired glucose tolerance and indeterminate glycemia in cystic fibrosis.囊性纤维化患者的糖耐量受损和血糖情况不明
J Clin Transl Endocrinol. 2021 Nov 16;26:100275. doi: 10.1016/j.jcte.2021.100275. eCollection 2021 Dec.
8
Continuous glucose monitoring systems for monitoring cystic fibrosis-related diabetes.用于监测囊性纤维化相关性糖尿病的连续血糖监测系统。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013755. doi: 10.1002/14651858.CD013755.pub2.
9
Drug treatments for managing cystic fibrosis-related diabetes.用于治疗囊性纤维化相关糖尿病的药物疗法。
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD004730. doi: 10.1002/14651858.CD004730.pub5.
10
Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach.囊性纤维化相关糖尿病:采用多学科方法优化治疗
Diabetes Metab Syndr Obes. 2019 Apr 26;12:545-552. doi: 10.2147/DMSO.S180597. eCollection 2019.